Island Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Island Pharmaceuticals has a total shareholder equity of A$637.8K and total debt of A$507.8K, which brings its debt-to-equity ratio to 79.6%. Its total assets and total liabilities are A$1.8M and A$1.1M respectively.
Key information
79.6%
Debt to equity ratio
AU$507.83k
Debt
| Interest coverage ratio | n/a |
| Cash | AU$976.05k |
| Equity | AU$637.76k |
| Total liabilities | AU$1.13m |
| Total assets | AU$1.77m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ILA's short term assets (A$1.8M) exceed its short term liabilities (A$1.1M).
Long Term Liabilities: ILA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ILA has more cash than its total debt.
Reducing Debt: Insufficient data to determine if ILA's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ILA has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ILA is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.